Mobile

Single-center, open-label, uncontrolled study to investigate the effects of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestodene (material no. 80876395) on the ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-010599-45

Single-center, open-label, uncontrolled study to investigate the effects of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestodene (material no. 80876395) on the endometrium in a 21-day regimen for 13 cycles in 80 healthy women

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to investigate the effect of the transdermal contraceptive patch (material no. 80876395, FC Patch Low containing 0.55 mg EE and 2.1 mg GSD) on the endometrium.

Critère d'inclusion

  • Healthy volunteer trial, intended indication: Prevention of pregnancy

Liens